Autophagy in T lymphocyte function

T 淋巴细胞功能中的自噬

基本信息

项目摘要

DESCRIPTION (provided by applicant): Macroautophagy (hereafter referred to as "autophagy") is a well-conserved catabolic process in eukaryotic cells. It is defined by the formation of double membrane autophagosome vesicles and functions in the intracellular degradation of cytosol and organelles. Although autophagy has long been recognized, its functions in various physiological and pathological processes have only begun to be elucidated. Our recent work has demonstrated that primary T lymphocytes have the capacity to undergo autophagy and that the autophagy gene Atg5 is essential for T cell survival and proliferation, suggesting that autophagy is a novel mechanism regulating mature T cell homeostasis. However, the underlying molecular mechanisms by which autophagy promotes T lymphocyte survival and proliferation remain unknown. Specifically, it is not clear whether the defect in Atg5-/- T cells is caused by an inability to form autophagosomes or an autophagy-independent function of Atg5? More importantly, if impaired autophagy compromises T cell survival, by what mechanism does autophagy inhibit death in T lymphocytes? Using conditional deletion of a second autophagy gene, Atg7, in T lymphocytes, we have established an essential role for autophagy in the survival of naive T lymphocytes. We have found that mitochondrial homeostasis is disrupted in T cells lacking Atg5 or Atg7. These results suggest that autophagy plays a key role in T cell function through maintaining the homeostasis of intracellular organelles. Our overall hypothesis is that autophagic function in mature primary T lymphocytes is required for cell survival and TCR-mediated proliferation through maintaining turnover of cytoplasmic material, in particular the essential organelle structures such as mitochondria. We proposed three specific aims to test this hypothesis. In aim 1, we will determine how autophagy is regulated in primary T lymphocytes and the developmental stages at which the induction of autophagy contributes to cell survival. In aim 2, we will examine how deregulation of organelle homeostasis contributes to cell death in autophagy-deficient primary T lymphocytes. In aim 3, we will establish the mechanisms by which loss of autophagy genes inhibits cell cycle progression during T cell proliferation. Results from this study will shed important insights to the molecular mechanisms by which mature T cell function is regulated. Better understanding this process will undoubtedly help future design of strategies boosting T cell immune responses to pathogens. PUBLIC HEALTH RELEVANCE: We propose to study the roles of an essential intracellular process termed autophagy in regulating T lymphocyte survival and proliferation. The results from this study, if funded, will provide important information for the treatment and prevention of diseases related to T lymphocytes including designing vaccines to boost T cell immune response to microbial pathogens, tumor genesis and autoimmune disease development.
描述(由申请人提供):大型噬菌体(以下称为“自噬”)是真核细胞中保存良好的分解代谢过程。它是由双膜自噬体囊泡的形成以及在细胞内降解细胞质和细胞器中的功能的定义。尽管长期以来已经认识到自噬,但其在各种生理和病理过程中的功能才开始阐明。我们最近的工作表明,原发性T淋巴细胞具有进行自噬的能力,并且自噬基因ATG5对于T细胞的存活和增殖至关重要,这表明自噬是调节成熟T细胞稳态的新型机制。然而,自噬促进淋巴细胞存活和增殖的潜在分子机制仍然未知。具体而言,尚不清楚ATG5 - / - T细胞中的缺陷是由于无法形成自噬体或ATG5的自噬函数引起的吗?更重要的是,如果自噬受损会损害T细胞的存活,那么自噬会抑制T淋巴细胞死亡的哪种机制?在T淋巴细胞中,使用第二个自噬基因ATG7的条件缺失,我们在幼稚T淋巴细胞生存中确立了自噬的重要作用。我们发现线粒体稳态在缺乏ATG5或ATG7的T细胞中被破坏。这些结果表明,通过维持细胞内细胞器的稳态,自噬在T细胞功能中起关键作用。我们的总体假设是,通过维持细胞质材料的周转,尤其是基本的细胞器结构,例如线粒体,需要进行成熟原发性T淋巴细胞的自噬功能才能进行细胞存活和TCR介导的增殖。我们提出了三个特定的目的来检验这一假设。在AIM 1中,我们将确定在原发性T淋巴细胞中如何调节自噬以及自噬诱导有助于细胞存活的发育阶段。在AIM 2中,我们将研究细胞器稳态的失调如何导致自噬的原发性T淋巴细胞的细胞死亡。在AIM 3中,我们将确定自噬基因损失抑制T细胞增殖过程中细胞周期进程的机制。这项研究的结果将对调节成熟T细胞功能的分子机制提供重要的见解。更好地了解这一过程将无疑有助于未来的设计策略,从而增强对病原体的T细胞免疫反应。公共卫生相关性:我们建议研究一种基本的细胞内过程,该过程称为自噬在调节T淋巴细胞生存和增殖中的作用。这项研究的结果(如果资助)将提供重要信息,以治疗和预防与T淋巴细胞有关的疾病,包括设计疫苗以增强对微生物病原体,肿瘤起源和自身免疫性疾病发展的T细胞免疫反应。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

You-Wen He的其他基金

The impact of genetic diversity among Akkermansia strains on the effectivenes of immune checkpoint inhibitors in cancer immunotherapies
阿克曼氏菌菌株遗传多样性对癌症免疫治疗中免疫检查点抑制剂有效性的影响
  • 批准号:
    10115682
    10115682
  • 财政年份:
    2020
  • 资助金额:
    $ 38.61万
    $ 38.61万
  • 项目类别:
A novel pathway regulating cytokine production and asthma development
调节细胞因子产生和哮喘发展的新途径
  • 批准号:
    7356481
    7356481
  • 财政年份:
    2009
  • 资助金额:
    $ 38.61万
    $ 38.61万
  • 项目类别:
A novel pathway regulating cytokine production and asthma development
调节细胞因子产生和哮喘发展的新途径
  • 批准号:
    7843494
    7843494
  • 财政年份:
    2009
  • 资助金额:
    $ 38.61万
    $ 38.61万
  • 项目类别:
Autophagy in T lymphocyte function
T 淋巴细胞功能中的自噬
  • 批准号:
    8461210
    8461210
  • 财政年份:
    2009
  • 资助金额:
    $ 38.61万
    $ 38.61万
  • 项目类别:
Autophagy in T lymphocyte function
T 淋巴细胞功能中的自噬
  • 批准号:
    8050675
    8050675
  • 财政年份:
    2009
  • 资助金额:
    $ 38.61万
    $ 38.61万
  • 项目类别:
Autophagy in T lymphocyte function
T 淋巴细胞功能中的自噬
  • 批准号:
    8260354
    8260354
  • 财政年份:
    2009
  • 资助金额:
    $ 38.61万
    $ 38.61万
  • 项目类别:
Autophagy in T lymphocyte function
T 淋巴细胞功能中的自噬
  • 批准号:
    7590040
    7590040
  • 财政年份:
    2009
  • 资助金额:
    $ 38.61万
    $ 38.61万
  • 项目类别:
BcI-2 family in T lymphocyte homeostasis
Bcl-2 家族在 T 淋巴细胞稳态中的作用
  • 批准号:
    8389558
    8389558
  • 财政年份:
    2008
  • 资助金额:
    $ 38.61万
    $ 38.61万
  • 项目类别:
Function of thymic epithelial cells in T lymphocyte maturation
胸腺上皮细胞在T淋巴细胞成熟中的功能
  • 批准号:
    7686243
    7686243
  • 财政年份:
    2008
  • 资助金额:
    $ 38.61万
    $ 38.61万
  • 项目类别:
BcI-2 family in T lymphocyte homeostasis
Bcl-2 家族在 T 淋巴细胞稳态中的作用
  • 批准号:
    7580414
    7580414
  • 财政年份:
    2008
  • 资助金额:
    $ 38.61万
    $ 38.61万
  • 项目类别:

相似国自然基金

MyD88介导树突状细胞分泌TNF调控EAE发生机制研究
  • 批准号:
    82371350
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
索拉非尼通过诱导调节性T细胞抑制自身免疫性疾病的研究
  • 批准号:
    32370955
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
自身免疫性疾病相关因子VGLL3调控DNA损伤应答与肿瘤免疫微环境重塑研究
  • 批准号:
    82341006
  • 批准年份:
    2023
  • 资助金额:
    150 万元
  • 项目类别:
    专项基金项目
自身免疫性疾病精准诊疗中基于非编码RNA组学和生物信息学的新方法研究
  • 批准号:
    82371855
  • 批准年份:
    2023
  • 资助金额:
    74 万元
  • 项目类别:
    面上项目
核苷酸转移酶cGAS乙酰化修饰抑制剂的设计、合成及抗自身免疫性疾病的机制研究
  • 批准号:
    82273767
  • 批准年份:
    2022
  • 资助金额:
    51 万元
  • 项目类别:
    面上项目

相似海外基金

Chromogranin A is an aging risk factor
嗜铬粒蛋白 A 是衰老的危险因素
  • 批准号:
    10667265
    10667265
  • 财政年份:
    2023
  • 资助金额:
    $ 38.61万
    $ 38.61万
  • 项目类别:
Apelin Signaling in Muscle Regeneration
肌肉再生中的 Apelin 信号转导
  • 批准号:
    10557030
    10557030
  • 财政年份:
    2023
  • 资助金额:
    $ 38.61万
    $ 38.61万
  • 项目类别:
Exploring Determinants of Intrinsic DNA Load Towards Inflammaging
探索导致炎症的内在 DNA 负荷的决定因素
  • 批准号:
    10373598
    10373598
  • 财政年份:
    2022
  • 资助金额:
    $ 38.61万
    $ 38.61万
  • 项目类别:
Exploring Determinants of Intrinsic DNA Load Towards Inflammaging
探索导致炎症的内在 DNA 负荷的决定因素
  • 批准号:
    10576391
    10576391
  • 财政年份:
    2022
  • 资助金额:
    $ 38.61万
    $ 38.61万
  • 项目类别:
Bone marrow NPY deficiency triggers HSC aging
骨髓 NPY 缺乏引发 HSC 衰老
  • 批准号:
    10352888
    10352888
  • 财政年份:
    2021
  • 资助金额:
    $ 38.61万
    $ 38.61万
  • 项目类别: